Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-05 Sale | 2024-09-05 7:50 pm | Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO | 2,525 | $0.566 | $1,429 | 20,870 (Direct) | View |
2024-01-05 Sale(A) | 2024-02-16 4:40 pm | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 2,412 | $2.91 | $7,019 | 13,395 (Direct) | View |
2024-01-05 Sale | 2024-01-08 4:35 pm | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 2,412 | $2.91 | $7,019 | 13,395 (Direct) | View |
2022-06-23 Sale | 2022-06-24 7:50 pm | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 4,193 | $2.69 | $11,279 | 5,807 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-03 Option Award | 2024-09-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO | 10,000 | $0 | 20,870 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 4:46 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 300,000 | $0 | 300,000 (Direct) | View |
2024-01-04 Option Award(A) | 2024-02-16 4:40 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 10,000 | $0 | 13,395 (Direct) | View |
2024-01-04 Option Award | 2024-01-08 4:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 10,000 | $0 | 13,395 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 5:45 pm | N/A 2033-01-18 | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 200,000 | $0 | 200,000 (Direct) | View |
2022-06-22 Option Award | 2022-06-24 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 10,000 | $0 | 5,807 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:31 pm | N/A 2032-01-17 | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 180,000 | $0 | 180,000 (Direct) | View |
2021-11-03 Option Award | 2021-11-05 5:02 pm | N/A 2031-11-02 | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2021-06-14 4:58 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Technology Officer | 0 | $0 | 0 (Direct) | View |